专利信息

首页 1 2 3 4 5 6 下页尾页共 94 条记录, 当前第1/10页。

专利标题：Pharmaceutical composition of levamlodipine or pharmaceutically acceptable salt thereof and beta receptor blocking agent, and use thereof

A pharmaceutical composition of levamlodipine or a pharmaceutically acceptable salt thereof and a p receptor blocking agent and a use thereof are provided. An active ingredient of the pharmaceutical composition contains levamlodipine or a pharmaceutically 5 acceptable salt thereof and a p receptor blocking agent in which the P receptor blocking agent is one selected from nebivolol bisoprolol betaxolol celiprolol and nadolol. A use of the pharmaceutical composition in preparation of a medicine fo...

专利标题：Pharmaceutical composition of levamlodipine or pharmaceutically acceptable salt thereof and .beta. receptor blocking agent, and use thereof

A pharmaceutical composition of levamlodipine or a pharmaceutically acceptable salt thereof and a .beta. receptor blocking agent and a use thereof are provided. An active ingredient of the pharmaceutical composition contains levamlodipine or a pharmaceutically acceptable salt thereof and a .beta. receptor blocking agent in which the .beta. receptor blocking agent is one selected from nebivolol bisoprolol betaxolol celiprolol and nadolol. A use of the pharmaceutical composition in preparation of ...

专利标题：The preparation method of l-betaxolol hydrochloride

专利标题：Betaxolol hydrochloride ion-sensitive eye-use in-situ gel and preparation method thereof

专利权人：UNIV GUIZHOU;

专利标题：[l]-amurojipin or that the medicine composition, and its use of the salt and the i receptor cutoff medicine which are allowed pharmacy

A pharmaceutical composition of levamlodipine or a pharmaceutically acceptable salt thereof and a **2 receptor blocking agent and a use thereof are provided.An active ingredient of the pharmaceutical composition contains levamlodipine or a pharmaceutically acceptable salt thereof and a **2 receptor blocking agent in which the **2 receptor blocking agent is one selected from nebivolol bisoprolol betaxolol celiprolol and nadolol.A use of the pharmaceutical composition in preparation of a medicine ...

专利标题：Capsulas de principios activos betabloqueantes y esteres de acidos grasos poliinsaturados

专利权人：Gp Pharm S.a.;

Composicion farmacéutica de administracion oral que contiene ésteres alquílicos de ácidos grasos poliinsaturados (PUFA) y principios activos farmacéuticos betabloqueantes para el tratamiento y/o prevencion de enfermedades cardiovasculares. Reivindicacion 2: Composicion farmacéutica segun la reivindicacion 1 donde los ácidos grasos poliinsaturados de dichos ésteres alquílicos pertenecen a la serie omega-3. Reivindicacion 4: Composicion farmacéutica segun la reivindicacion 1 donde el radical alqui...

专利标题：Pharmaceutical composition of levamlodipine or pharmaceutically acceptable salt thereof and &bgr; receptor blocking agent, and use thereof

A pharmaceutical composition of levamlodipine or a pharmaceutically acceptable salt thereof and a &bgr; receptor blocking agent and a use thereof are provided. An active ingredient of the pharmaceutical composition contains levamlodipine or a pharmaceutically acceptable salt thereof and a &bgr; receptor blocking agent in which the &bgr; receptor blocking agent is one selected from nebivolol bisoprolol betaxolol celiprolol and nadolol. A use of the pharmaceutical composition in preparation of a m...

专利标题：Therapeutic agent for glaucoma comprising rho kinase inhibitor and ss- blocker

专利权人：SANTEN PHARMA CO LTD [JP];

A therapeutic agent for glaucoma including a combination of pharmaceutically effective amounts of a Rho kinase inhibitor and a [beta]-blocker, wherein the Rho kinase inhibitor is (R)-(+)-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)-4-(1-aminoethyl)benzamide and the [beta]-blocker is befunolol, carteolol, nipradilol, betaxolol, levobunolol or metipranolol. A method of treating glaucoma including administering effective amounts of a Rho kinase inhibitor and a [beta]-blocker to a patient, wherein the Rho kina...

专利标题：The pharmaceutical composition of a kind of levamlodipine or its officinal salt and beta-blocker and application thereof

专利标题：Pharmaceutical composition of levamlodipine or pharmaceutically acceptable salt thereof and beta receptor blocking agent, and use thereof

当前查询条件: [药品] 包含 'Betaxolol'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. AU2010276461B2	2013/12/5	AU20100276461	2010/6/22
专利标题：Pharmaceutical composition of levamlodipine or pharmaceutically acceptable salt thereof and beta receptor blocking agent, and use thereof 专利权人：Shihuida Pharmaceuticals Group (jilin) Ltd; A pharmaceutical composition of levamlodipine or a pharmaceutically acceptable salt thereof and a p receptor blocking agent and a use thereof are provided. An active ingredient of the pharmaceutical composition contains levamlodipine or a pharmaceutically 5 acceptable salt thereof and a p receptor blocking agent in which the P receptor blocking agent is one selected from nebivolol bisoprolol betaxolol celiprolol and nadolol. A use of the pharmaceutical composition in preparation of a medicine fo...

2. CA2728997C	2013/10/15	CA20102728997	2010/6/22
专利标题：Pharmaceutical composition of levamlodipine or pharmaceutically acceptable salt thereof and .beta. receptor blocking agent, and use thereof 专利权人：Shihuida Pharmaceuticals Group (jilin) Ltd; A pharmaceutical composition of levamlodipine or a pharmaceutically acceptable salt thereof and a .beta. receptor blocking agent and a use thereof are provided. An active ingredient of the pharmaceutical composition contains levamlodipine or a pharmaceutically acceptable salt thereof and a .beta. receptor blocking agent in which the .beta. receptor blocking agent is one selected from nebivolol bisoprolol betaxolol celiprolol and nadolol. A use of the pharmaceutical composition in preparation of ...

3. CN101665441B	2013/4/10	CN20091195904	2009/9/18
专利标题：The preparation method of l-betaxolol hydrochloride 专利权人：Anhui Qingyun Pharmaceutical And Chemical Co., Ltd.;

4. CN102727423A	2012/10/17	CN20121203569	2012/6/20
专利标题：Betaxolol hydrochloride ion-sensitive eye-use in-situ gel and preparation method thereof 专利权人：UNIV GUIZHOU;

5. JP2012514049A	2012/6/21	JP20110553273	2010/6/22
专利标题：[l]-amurojipin or that the medicine composition, and its use of the salt and the i receptor cutoff medicine which are allowed pharmacy 专利权人： A pharmaceutical composition of levamlodipine or a pharmaceutically acceptable salt thereof and a 2 receptor blocking agent and a use thereof are provided.An active ingredient of the pharmaceutical composition contains levamlodipine or a pharmaceutically acceptable salt thereof and a 2 receptor blocking agent in which the **2 receptor blocking agent is one selected from nebivolol bisoprolol betaxolol celiprolol and nadolol.A use of the pharmaceutical composition in preparation of a medicine ...

6. AR079430A1	2012/1/25	AR2010P104272	2010/11/18
专利标题：Capsulas de principios activos betabloqueantes y esteres de acidos grasos poliinsaturados 专利权人：Gp Pharm S.a.; Composicion farmacéutica de administracion oral que contiene ésteres alquílicos de ácidos grasos poliinsaturados (PUFA) y principios activos farmacéuticos betabloqueantes para el tratamiento y/o prevencion de enfermedades cardiovasculares. Reivindicacion 2: Composicion farmacéutica segun la reivindicacion 1 donde los ácidos grasos poliinsaturados de dichos ésteres alquílicos pertenecen a la serie omega-3. Reivindicacion 4: Composicion farmacéutica segun la reivindicacion 1 donde el radical alqui...

7. US20110313006A1	2011/12/22	US13/123617	2010/6/22
专利标题：Pharmaceutical composition of levamlodipine or pharmaceutically acceptable salt thereof and &bgr; receptor blocking agent, and use thereof 专利权人：Shihuida Pharmaceuticals Group (jilin) Ltd.; A pharmaceutical composition of levamlodipine or a pharmaceutically acceptable salt thereof and a &bgr; receptor blocking agent and a use thereof are provided. An active ingredient of the pharmaceutical composition contains levamlodipine or a pharmaceutically acceptable salt thereof and a &bgr; receptor blocking agent in which the &bgr; receptor blocking agent is one selected from nebivolol bisoprolol betaxolol celiprolol and nadolol. A use of the pharmaceutical composition in preparation of a m...

8. US2011263638A1	2011/10/27	US201113135295	2011/6/30
专利标题：Therapeutic agent for glaucoma comprising rho kinase inhibitor and ss- blocker 专利权人：SANTEN PHARMA CO LTD [JP]; A therapeutic agent for glaucoma including a combination of pharmaceutically effective amounts of a Rho kinase inhibitor and a [beta]-blocker, wherein the Rho kinase inhibitor is (R)-(+)-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)-4-(1-aminoethyl)benzamide and the [beta]-blocker is befunolol, carteolol, nipradilol, betaxolol, levobunolol or metipranolol. A method of treating glaucoma including administering effective amounts of a Rho kinase inhibitor and a [beta]-blocker to a patient, wherein the Rho kina...

9. CN101766611B	2011/10/12	CN20101107915	2010/2/9
专利标题：The pharmaceutical composition of a kind of levamlodipine or its officinal salt and beta-blocker and application thereof 专利权人：Shihuida Pharmaceutical Group (jilin) Co., Ltd.;

10. AU2010276461A1	2011/8/25	AU20100276461	2010/6/22
专利标题：Pharmaceutical composition of levamlodipine or pharmaceutically acceptable salt thereof and beta receptor blocking agent, and use thereof 专利权人：Shihuida Pharmaceuticals Group (jilin) Ltd; A pharmaceutical composition of levamlodipine or a pharmaceutically acceptable salt thereof and a p receptor blocking agent and a use thereof are provided. An active ingredient of the pharmaceutical composition contains levamlodipine or a pharmaceutically 5 acceptable salt thereof and a p receptor blocking agent in which the P receptor blocking agent is one selected from nebivolol bisoprolol betaxolol celiprolol and nadolol. A use of the pharmaceutical composition in preparation of a medicine fo...

下载范围

下载内容